Page last updated: 2024-09-03

nitroflurbiprofen and Hyperplasia

nitroflurbiprofen has been researched along with Hyperplasia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cirino, G; del Soldato, P; Ialenti, A; Ianaro, A; Lippolis, L; Maffia, P; Maiello, FM; Sorrentino, R	1

Other Studies

1 other study(ies) available for nitroflurbiprofen and Hyperplasia

Article	Year
Beneficial effects of NO-releasing derivative of flurbiprofen (HCT-1026) in rat model of vascular injury and restenosis. Arteriosclerosis, thrombosis, and vascular biology, 2002, Feb-01, Volume: 22, Issue:2 Topics: Administration, Oral; Angioplasty, Balloon, Coronary; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carotid Arteries; Coronary Restenosis; Dose-Response Relationship, Drug; Flurbiprofen; Hyperplasia; Immunohistochemistry; Male; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Proliferating Cell Nuclear Antigen; Rats; Rats, Wistar; Stomach Diseases; Tunica Intima	2002

Article

Year

Beneficial effects of NO-releasing derivative of flurbiprofen (HCT-1026) in rat model of vascular injury and restenosis.

Arteriosclerosis, thrombosis, and vascular biology, 2002, Feb-01, Volume: 22, Issue:2

Topics: Administration, Oral; Angioplasty, Balloon, Coronary; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carotid Arteries; Coronary Restenosis; Dose-Response Relationship, Drug; Flurbiprofen; Hyperplasia; Immunohistochemistry; Male; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Proliferating Cell Nuclear Antigen; Rats; Rats, Wistar; Stomach Diseases; Tunica Intima

2002